Christopher J. Oalmann
GlaxoSmithKline (United States)(US)Tris Pharma (United States)(US)
Publications by Year
Research Areas
Cyclopropane Reaction Mechanisms, Asymmetric Synthesis and Catalysis, Catalytic Alkyne Reactions, Asymmetric Hydrogenation and Catalysis, Corporate Taxation and Avoidance
Most-Cited Works
- → Enantioselective Intramolecular Cyclopropanations of Allylic and Homoallylic Diazoacetates and Diazoacetamides Using Chiral Dirhodium(II) Carboxamide Catalysts(1995)215 cited
- → Crystallographic structure of a small molecule SIRT1 activator-enzyme complex(2015)198 cited
- → High enantioselectivity in the intramolecular cyclopropanation of allyl diazoacetates using a novel rhodium(II) catalyst(1991)198 cited
- → 1,2,3-Trisubstituted cyclopropanes as conformationally restricted peptide isosteres: application to the design and synthesis of novel renin inhibitors(1992)91 cited
- → Cyclopropanes as conformationally restricted peptide isosteres. Design and synthesis of novel collagenase inhibitors(1993)75 cited
- → Enantioselective, rhodium catalyzed intramolecular cyclopropanations of homoallylic diazoacetates.(1992)48 cited
- → Stereoselective synthesis of 1,2,3-trisubstituted cyclopropanes as novel dipeptide isosteres(1990)24 cited
- → The Identification of the SIRT1 Activator SRT2104 as a Clinical Candidate(2013)18 cited
- → ChemInform Abstract: Enantioselective Intramolecular Cyclopropanations of Allylic and Homoallylic Diazoacetates and Diazoacetamides Using Chiral Dirhodium( II) Carboxamide Catalysts.(1995)1 cited
- → ChemInform Abstract: Stereoselective Synthesis of 1,2,3‐Trisubstituted Cyclopropanes as Novel Dipeptide Isosters.(1991)